Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280743 · ClinicalTrials.gov registry record
Precision Opioid Care After Cesarean Delivery (PRECISE-CD)
A clinical trial, sponsored by Grace Lim, MD, MS.
- Completed
- Registry status
- 341
- Enrollment target
NCT05280743: Completed study, sponsored by Grace Lim, MD, MS.
NCT05280743 is a clinical trial that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 341 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05280743 has completed, sponsored by Grace Lim, MD, MS.
- COMPLETED
- Registry status
- 341 participants
- Enrollment target
Study Summary
The purpose of this research is to study serious clinical problems from surgical pain and the use of oxycodone or other opioids in women having a Cesarean Delivery to improve the safety and efficacy of surgical pain relief. This research will ultimately improve the safety and efficacy of surgical pain relief with opioids by preoperative risk predictions and personalized care with the right dose of the right analgesic for each patient.
Primary Outcome
Respiratory depression (RD) measured as Yes or No in occurrence.
Interventions
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2024-06-01 |
What the finished NCT05280743 record still lists
NCT05280743 is an observational study that tracks outcomes without assigning an intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Oxycodone is the first listed.
NCT05280743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05280743 about?
NCT05280743 is a clinical study titled "Precision Opioid Care After Cesarean Delivery (PRECISE-CD)". The purpose of this research is to study serious clinical problems from surgical pain and the use of oxycodone or other opioids in women having a Cesarean Delivery to improve the safety and efficacy of surgical pain relief. This research will ultimately improve the safety and efficacy of surgical pa...
What is the current status of trial NCT05280743?
This trial is currently completed. The enrollment target is 341 participants. The study started on 2022-03-28. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05280743?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT05280743?
This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI